Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (111-120 of 550) with videos related to

Pageof 55
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Graft versus host and auto-immune reactions may explain the discontinuity and severity of HIV-1-AIDS diseaseG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Are HIV-1 seropositive subjects submitted to one of the innumerable AZT randomized double-blind trials, definitively victims of cross and/or common resistance to all virostatics, even in combinations?G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cancer versus Alzheimer risks. Health is not moralG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
The kinetics of cancer cells and of HIV1: the problems of cell and virus rebounds and of latencyG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Are sexually transmitted papilloma viruses exclusive, necessary and sufficient causative factors of genital organ invasive or in situ neoplasia?G Mathé
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
[Hamao Umezawa]G Mathé
La Nouvelle Presse Medicale|July 2, 1977
[Towards dismembering the so-called acute lymphoid leukemia]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Lessons from past experience in cancer immunotherapy and their application to cancer and AIDS treatment and prophylaxisG Mathé
Advances in Cancer Research|January 1, 1971
Active immunotherapyG Mathé
Pageof 55

Showing results (111-120 of 550) with videos related to

Sort By:
Pageof 55
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Graft versus host and auto-immune reactions may explain the discontinuity and severity of HIV-1-AIDS diseaseG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Are HIV-1 seropositive subjects submitted to one of the innumerable AZT randomized double-blind trials, definitively victims of cross and/or common resistance to all virostatics, even in combinations?G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Cancer versus Alzheimer risks. Health is not moralG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 28, 1999
The kinetics of cancer cells and of HIV1: the problems of cell and virus rebounds and of latencyG Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Are sexually transmitted papilloma viruses exclusive, necessary and sufficient causative factors of genital organ invasive or in situ neoplasia?G Mathé
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
[Hamao Umezawa]G Mathé
La Nouvelle Presse Medicale|July 2, 1977
[Towards dismembering the so-called acute lymphoid leukemia]G Mathé
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Lessons from past experience in cancer immunotherapy and their application to cancer and AIDS treatment and prophylaxisG Mathé
Advances in Cancer Research|January 1, 1971
Active immunotherapyG Mathé
Pageof 55